OPR - Delayed Quote • USD SNY Sep 2024 50.000 call (SNY240920C00050000) Follow 1.9300 0.0000 (0.00%) At close: April 25 at 10:57 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for SNY240920C00050000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: SNY Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge Sanofi (SNY) Q1 2024 Earnings Call Transcript 20 Fastest Growing Health Tech Companies in the World Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up Sanofi Sales, Profit Beat Expectations UPDATE 2-Sanofi profit slips on generic competition and currency effects Sanofi profit slips on generic competition and currency effects Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance What's in Store for These 5 Pharma Bigwigs in Q1 Earnings? Sanofi Asks Banks to Pitch for $20 Billion OTC Spinoff Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
